Latest News
OPEC’s exports account for nearly 50% of all the world’s crude exports, and the organization and its allies hold almost 80% of the world’s oil reserves.
Via Stocktwits · December 3, 2025
Pharvaris stock surged Wednesday on promising test results for an HAE drug.
Via Investor's Business Daily · December 3, 2025
Pharvaris reports Phase 3 data showing its oral HAE treatment delivers rapid relief, fewer second doses and strong safety results.
Via Benzinga · December 3, 2025
Via Benzinga · December 3, 2025
The HOPE-3 study, involving 106 participants across 20 U.S. centres, delivered strong signals of benefit for muscle and heart function.
Via Stocktwits · December 3, 2025
Via Benzinga · December 3, 2025
Intel Corp (NASDAQ: INTC) stock has surged over 20% in the past five trading sessions. Here's what you need to know.
Via Benzinga · December 3, 2025
Shares of this cybersecurity specialist have pulled back substantially as of late, which could present an opportunity for savvy investors.
Via The Motley Fool · December 3, 2025
Via Benzinga · December 3, 2025
Via Benzinga · December 3, 2025
Via Benzinga · December 3, 2025
Via Benzinga · December 3, 2025
Via Benzinga · December 3, 2025
Via Benzinga · December 3, 2025
Via Benzinga · December 3, 2025
Via Benzinga · December 3, 2025
Via Benzinga · December 3, 2025
Via Benzinga · December 3, 2025
Tesla’s European Woes Deepen As November Registrations Decline 20% In Germanystocktwits.com
Via Stocktwits · December 3, 2025
Via Benzinga · December 3, 2025
Via Benzinga · December 3, 2025
With IonQ bringing quantum computing into healthcare, is now the time for investors to start paying attention to this stock?
Via Barchart.com · December 3, 2025
Here's why the answer is more complicated than it seems.
Via The Motley Fool · December 3, 2025
Precious metals are on the rise again. The moves have generated investor interest amid the market’s unusual dynamics.
Via Talk Markets · December 3, 2025
JPMorgan is still making disruptive moves in blockchain as Bitcoin prices plunge nearly 30% in a matter of a few short weeks.
Via Barchart.com · December 3, 2025
Bristol Myers Squibb stock popped Wednesday after the firm delayed a study testing Cobenfy in Alzheimer's disease psychosis.
Via Investor's Business Daily · December 3, 2025
You might not see it, but it can be costly for companies not to take it seriously.
Via The Motley Fool · December 3, 2025
Bitcoin (CRYPTO: BTC) gained fresh attention on Wednesday after Strategy executive chairman
Via Benzinga · December 3, 2025
While Prudential Financial has outperformed its sector peers recently, analysts remain cautious about the stock’s prospects.
Via Barchart.com · December 3, 2025
Industrial Production in September rose just 0.1% MoM (as expected), up from the downwardly revised 0.3% MoM decline in August.
Via Talk Markets · December 3, 2025

As Paychex has notably underperformed the Dow recently, analysts remain cautious about the stock’s prospects.
Via Barchart.com · December 3, 2025
Via Benzinga · December 3, 2025
According to The Information report, less than 20% of employees in the Azure cloud division reached their projected Foundry sales growth, prompting a revision of annual targets.
Via Stocktwits · December 3, 2025
Via Benzinga · December 3, 2025
One investor is making a bold bet on Amylyx just as its 2026 catalyst calendar starts to take shape.
Via The Motley Fool · December 3, 2025
